Patient info Search Menu

Zolmitriptan Rapimelt 2.5 mg orodispersible tablets, Zomig Rapimelt 2.5 mg orodispersible tablets – patient leaflet, side effects, dosage

Updated:
Key facts
Status:
Prescription only (POM)
Medicine strength:
2.5 mg
Contains active substance:

Patient leaflet - Zolmitriptan Rapimelt 2.5 mg orodispersible tablets, Zomig Rapimelt 2.5 mg orodispersible tablets

1. What Zomig Rapimelt is and what it is used for

Zomig Rapimelt contains zolmitriptan and belongs to a group of medicines called triptans.

Zomig Rapimelt is used to treat migraine headache.

  • Migraine symptoms may be

    caused by swollen blood vessels in the head. Zomig Rapimelt is thought to reduce the widening of these blood vessels. This helps to take away the headache and other symptoms of a migraine attack, such as feeling or being sick (nausea or vomiting) and being sensitive to light and sound.

  • Zomig Rapimelt works only when

    a migraine attack has started. It will not stop you from getting an attack.

2. What you need to know before you take Zomig Rapimelt

Do not take Zomig Rapimelt:

  • If you are allergic to zolmitriptan

    or any of the other ingredients of this medicine (listed in Section 6).

  • If you have high blood pressure.
  • If you have ever had heart

    problems, including a heart attack, angina (chest pain caused by exercise or effort),

    Prinzmetal’s angina (chest pain which happens at rest) or have experienced heart related symptoms such as shortness of breath or pressure over the chest.

  • If you have had a stroke or short-

    lasting symptoms similar to stroke (transient ischaemic attack or TIA).

  • If you are at the same time taking

    some other medicines for migraine (e.g. ergotamine or ergot-type medicines like dihydroergotamine and

    methysergide) or other triptan medicines for migraine. See ‘Other medicines and Zomig Rapimelt’ for further information.

    Do not take Zomig Rapimelt if any of the above apply to you. If you are not sure, talk to your doctor or

    pharmacist before taking Zomig Rapimelt.

    Warnings and precautions

    Talk to your doctor or pharmacist before taking Zomig Rapimelt:

    • If you are at risk of getting

      ischaemic heart disease (poor blood flow in the arteries of the heart). Your risk is greater if you smoke, have high blood pressure, high levels of

      cholesterol, diabetes or if anyone in your family has ischaemic heart disease.

    • If you have been told that you

      have Wolff-Parkinson-White Syndrome (a type of abnormal heart beat).

    • If you have ever had liver

      problems.

    • If you have headaches which are

      not like your usual migraine headache.

    • If you are taking any medicine for

      treatment of depression (see ‘Other medicines and Zomig Rapimelt’ for further information).

If you go into hospital tell the medical staff you are taking Zomig Rapimelt.

Zomig Rapimelt is not recommended for people aged over 65.

As with other migraine treatments, using too much Zomig Rapimelt can cause daily headaches or can make your migraine headaches worse. Ask your doctor if you think that this is the case for you. You may need to stop taking Zomig Rapimelt to correct the problem.

Children and adolescents

Zomig Rapimelt is not recommended in children and adolescents under 18 years.

Other medicines and Zomig Rapimelt

Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.

This includes herbal medicines and medicines you buy without

prescription.

In particular, tell your doctor if you are taking any of the following medicines:

Medicines for migraine

  • If you take a triptan other than

    Zomig Rapimelt (such as sumatriptan or naratriptan) leave 24 hours before taking Zomig Rapimelt.

  • After taking Zomig Rapimelt

    leave 24 hours before taking another triptan.

  • If you take medicines containing

    ergotamine or ergot-type medicines (such as

    dihydroergotamine or

    methysergide), leave 24 hours before taking Zomig Rapimelt.

  • After taking Zomig Rapimelt

    leave 6 hours before taking ergotamine or ergot-type medicines.

Medicines for depression

  • Mono-Amine Oxidase Inhibitors,

    also known as MAOIs (such as moclobemide).

  • SSRIs (selective serotonin

    reuptake inhibitors) such as fluoxetine, paroxetine,

    fluvoxamine or sertraline.

    • SNRIs (serotonin norepinephrine reuptake inhibitors) such as venlafaxine or duloxetine. Serotonin syndrome is a rare, life-threatening condition that has been reported in some patients who took Zomig Rapimelt in combination with so called serotoninergic medicines (e.g. certain medicines for the treatment of depression). Signs of serotonin syndrome may be for example agitation, restlessness, fever, excessive sweating, tremor, uncoordinated movement of limbs or eyes, uncontrollable jerking of muscles, twitching and muscle rigidity. Your doctor may advise you on this.

Other medicines

  • Cimetidine (for indigestion or stomach ulcers).
  • A quinolone antibiotic (such as ciprofloxacin).

You should not take the herbal remedy St. John’s wort (Hypericum perforatum) at the same time as this medicine.

If you already take a St. John’s wort preparation, stop taking it and mention this to your doctor at your next visit.

Zomig Rapimelt with food and drink

You can take Zomig Rapimelt with or without food. It does not affect the way that Zomig Rapimelt works.

Pregnancy, breast-feeding and fertility

It is not known if taking Zomig Rapimelt during pregnancy is harmful. If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.

Driving and using machines

During a migraine attack your reactions may be slower than usual. Bear this in mind when you drive or use any tools or machines. Zomig Rapimelt is unlikely to affect driving or using tools or machines. However, it may make you feel sleepy. Wait to see how Zomig Rapimelt affects you before you try these activities.

Zomig Rapimelt contains Aspartame (E951)

Zomig Rapimelt 2.5mg

orodispersible tablets contains 5mg aspartame per tablet.

Aspartame is a source of

phenylalanine. It may be harmful if you have phenylketonuria (PKU), a rare genetic disorder in which phenylalanine builds up because the body cannot remove it properly.

This medicine contains less than 1mmol sodium (23mg) per tablet, that is to say essentially ‘sodium-free’

3. How to take Zomig Rapimelt

Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.

You can take this medicine as soon as a migraine headache starts. You can also take it once an attack is underway.

  • The recommended dose is one tablet (2.5mg).

POM

  • Peel the blister pack open as

    shown on the foil. Do not push the tablet through the foil.

  • Place the tablet on your tongue,

    where it will dissolve and be swallowed with the saliva. You do not have to take a drink of water in order to swallow your tablet.

  • You can take another tablet if the

    migraine is still present after two hours or if it returns within 24 hours.

If the tablets did not give you enough help with your migraine, tell your doctor. Your doctor may change your treatment.

Do not use more than the dose prescribed for you.

  • Do not use more than two doses

    in one day unless prescribed by your doctor.

  • The maximum daily dose is

    10mg.

If you take more Zomig Rapimelt than you should

If you have taken more Zomig Rapimelt than prescribed by your doctor, talk to your doctor or pharmacist straight away or go to the nearest hospital straight away. Take this medicine with you.

If you forget to take Zomig Rapimelt

  • Do not take a double dose to

    make up for a forgotten dose.

If you have any further questions on the use of this medicine, ask your doctor or pharmacist.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them. Some of the symptoms below could be part of the migraine attack itself.

If you notice any of the following serious side effects, stop taking Zomig Rapimelt and contact a doctor straight away:

Rare (may affect up to 1 in 1,000 people):

  • Allergic reactions including itchy

    rash (urticaria) and swelling of the face, lips, mouth, tongue and throat.

Very rare (may affect up to 1 in 10,000 people):

  • Angina (pain in the chest, often

    brought on by exercise), heart attack or spasm of the blood vessels of the heart. The signs include chest pain and shortness of breath.

  • Spasm of the blood vessels of

    the gut, which can cause damage to your gut. The signs include stomach pain or bloody

    diarrhoea.

  • Bleeding in the brain (cerebral

    bleeding) or stroke.

Other possible side effects include:

Common (may affect up to 1 in 10 people):

These side effects are usually mild and go away after a short time.

  • Abnormal sensations such as

    tingling in your fingers and toes or skin that is sensitive to touch.

  • Feeling sleepy, dizzy or warm.
  • Headache.
  • Uneven heart beat.
  • Feeling sick (nausea) or being

    sick (vomiting).

  • Stomach pain.
  • Dry mouth.
  • Muscle weakness or muscle pain.
  • Feeling weak.
  • Heaviness, tightness, pain or

    pressure in the throat, neck, arms and legs, or chest.

    • Problems swallowing.

Uncommon (may affect up to 1 in 100 people):

  • Very fast heart beat.
  • Slightly higher blood pressure.
  • Increase in the amount of water you pass (urine) or in how often you need to pass water.

Reporting of side effects

If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at:

www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.

By reporting side effects, you can help provide more information on the safety of this medicine.

5. How to store Zomig Rapimelt

  • Do not store tablets above 30°C.
  • Keep your tablets in the container they came in.
  • If your doctor tells you to stop taking your tablets, take any tablets you have left back to the pharmacy for safe disposal. Only keep your tablets if your doctor tells you to.
  • Do not take your tablets after the expiry date on the container. Take any tablets that are out of date back to the pharmacy.
  • Keep your Zomig Rapimelt in a safe place, where children cannot see or reach them. Your tablets could harm them.
  • If the tablets become discoloured or show any signs of

    deterioration, you should seek the advice of your pharmacist.

6. Contents of the pack and other information

What Zomig Rapimelt 2.5mg orodispersible tablets contain

Each orodispersible tablet contains 2.5mg of Zomig as the active ingredient.

Your tablet also contains the following inactive ingredients: aspartame, citric acid anhydrous, silica colloidal anhydrous,

crospovidone, magnesium stearate, mannitol, microcrystalline cellulose, orange flavour SN027512 and sodium hydrogen carbonate.

What Zomig Rapimelt 2.5mg orodispersible tablets look like and contents of the pack

  • Each Zomig tablet is a white, round, bevelled edge,

    orodipsersible tablet marked with a ‘Z’ on one side and plain on the reverse.

  • Zomig comes in packs of

    2 orodispersible tablets

Manufacturered by: AstraZeneca U.K. Limited, Macclesfield, Cheshire, UK.

OR

Grünenthal GmbH, Zieglerstrasse 6- D- 52078 Aachen, Germany.

Procured from within the EU and repackaged by the Product Licence holder: B&S Healthcare, Unit 4, Bradfield Road, Ruislip, Middlesex, HA4 0NU, UK.

Zomig® Rapimelt® 2.5mg orodispersible tablets

PL 18799/1272

Leaflet date: 25.08.2020.

Zomig Rapimelt is a registered trademark of Grünenthal GmbH.

Blind or partially sighted?

Is this leaflet hard to see or read?

Call 0208 515 3763 to obtain the leaflet in a format suitable for you.

About this document

Source: MHRA - Medicines and Healthcare products Regulatory Agency (products.mhra.gov.uk)

Last revision stated in the text: 25 August 2020

What the sections and the side effect frequencies mean: How to read a patient leaflet

Found a mistake? Tell us on the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Facts about Zolmitriptan Rapimelt 2.5 mg orodispersible tablets, Zomig Rapimelt 2.5 mg orodispersible tablets

What these facts mean

Prescription needed?? Yes, prescription-only medicine (POM)
Active substance? Zolmitriptan
Strength? 2.5 mg
Pharmaceutical form? Orodispersible tablet
How is it taken? Oral
Is it available?? Listed as available (NHS Dictionary of Medicines and Devices – not a record of current supplies)
Drug group (ATC)?
  1. N Nervous system drugs
    1. N02 Analgesics
      1. N02C Antimigraine preparations
        1. N02CC Selective serotonin (5HT1) agonists, antimigraine drugs
          1. N02CC03 zolmitriptan
Marketing authorisation? PLPI 18799/1272
Codes? BNF 04070401

Sources: the MHRA product information (products.mhra.gov.uk) and the NHS Dictionary of Medicines and Devices (dm+d), release 11.1.0 of 9 November 2026, NHS Business Services Authority. Contains public sector information licensed under the Open Government Licence v3.0.